To better understand which Rasopathy sequelae result from hyperactivation of downstream MAPKs, we engineered mice with a gain-of-function mutation in the terminal MAPK gene Mapk1, which encodes ERK2 and is associated with the recently described genetic syndrome MAPK1-related Rasopathy (MRR). The gene discussed is MAPK1; the disease is RASopathy.